{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:38:11Z","timestamp":1790188691632,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Iridium-192 (\n                      <jats:sup>192<\/jats:sup>\n                      Ir) has been a widely accepted radioisotope for high-dose-rate (HDR) brachytherapy. Recently, Cobalt-60 (\n                      <jats:sup>60<\/jats:sup>\n                      Co) radioisotope with a longer half-life (5.26 years) has been gaining popularity due to economic and logistical reasons as compared with the traditional\n                      <jats:sup>192<\/jats:sup>\n                      Ir.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to evaluate and compare the integral dose (ID) to the target and organs at risk (OARs) with two HDR brachytherapy sources in brachytherapy treatment of carcinoma uterine cervix to find appropriate HDR radioisotopes for clinical benefit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This is a retrospective analysis of 52 computed tomography image-based brachytherapy plans of 52 patients who have received intracavitary treatment with\n                      <jats:sup>192<\/jats:sup>\n                      Ir HDR source. For each patient plan, one additional set of plan was created using\n                      <jats:sup>60<\/jats:sup>\n                      Co source in place of\n                      <jats:sup>192<\/jats:sup>\n                      Ir source keeping the same dwell position, and again dose was optimized. The volume and mean dose for target, OARs, and volume structures of 400%, 200%, 150%, 100%, and 50% were recorded for the estimation and comparison of ID.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean ID to high-risk clinical target volume was significantly higher by 5.84% in\n                      <jats:sup>60<\/jats:sup>\n                      Co plan than that in\n                      <jats:sup>192<\/jats:sup>\n                      Ir plan. For OARs, the mean ID to the rectum was significantly higher by 2.60% in\n                      <jats:sup>60<\/jats:sup>\n                      Co plan as compared to\n                      <jats:sup>192<\/jats:sup>\n                      Ir plan, whereas for bladder and sigmoid colon, it was lower in\n                      <jats:sup>60<\/jats:sup>\n                      Co plan than that in\n                      <jats:sup>192<\/jats:sup>\n                      Ir plan. The mean ID of central dose volume structures of 400%, 200%, 150%, 100%, and 50% was higher by 12.97%, 9.77%, 8.16%, 6.10%, and 3.22%, respectively, in\n                      <jats:sup>60<\/jats:sup>\n                      Co plan than that of\n                      <jats:sup>192<\/jats:sup>\n                      Ir plan.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The results of our study concluded that\n                      <jats:sup>192<\/jats:sup>\n                      Ir HDR radioisotope should be preferred for intracavitary brachytherapy due to its ideal physical characteristics for better clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_199_19","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T05:30:54Z","timestamp":1580189454000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Estimation and comparison of integral dose to target and organs at risk in three-dimensional computed tomography image-based treatment planning of carcinoma uterine cervix with two high-dose-rate brachytherapy sources"],"prefix":"10.4103","volume":"17","author":[{"given":"Suresh","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Saroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veenita","family":"Yogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20241021","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"R2-32-20241021","doi-asserted-by":"crossref","first-page":"20150010","DOI":"10.1259\/bjr.20150010","article-title":"Comparison of Axxent-Xoft, 192Ir and 60Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer","volume":"88","author":"Mobit","year":"2015","journal-title":"Br J Radiol"},{"key":"R3-32-20241021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5114\/jcb.2012.27952","article-title":"Treatment planning study of the 3D dosimetric differences between Co-60 and Ir-192 sources in high dose rate (HDR) brachytherapy for cervix cancer","volume":"4","author":"Palmer","year":"2012","journal-title":"J Contemp Brachytherapy"},{"key":"R4-32-20241021","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1148\/83.2.344","article-title":"Remote afterloading with intracavitary applicators","volume":"83","author":"Henschke","year":"1964","journal-title":"Radiology"},{"key":"R5-32-20241021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-6-11","article-title":"International conference on advances in radiation oncology (ICARO): Outcomes of an IAEA meeting","volume":"6","author":"Salminen","year":"2011","journal-title":"Radiat Oncol"},{"key":"R6-32-20241021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4137\/CMO.S5269","article-title":"High dose rate brachytherapy in the treatment of cervical cancer: Preliminary experience with cobalt 60 radionuclide source \u2013 A prospective study","volume":"4","author":"Ntekim","year":"2010","journal-title":"Clin Med Insights Oncol"},{"key":"R8-32-20241021","first-page":"125","article-title":"Co-60 verses Ir-192 in HDR brachytherapy: Scientific and technological comparison","volume":"13","author":"Andr\u00e1ssy","year":"2012","journal-title":"Rev Fis Med"},{"key":"R9-32-20241021","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.rpor.2016.03.005","article-title":"Study of the dosimetric differences between 192Ir and 60Co sources of high dose rate brachytherapy for breast interstitial implant","volume":"21","author":"Sinnatamby","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"R10-32-20241021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.rpor.2016.01.003","article-title":"Dosimetric analysis of Co-60 source based high dose rate (HDR) brachytherapy: A case series of ten patients with carcinoma of the uterine cervix","volume":"21","author":"Gurjar","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"R11-32-20241021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5114\/jcb.2011.26471","article-title":"Comparison of 60Co and 192Ir sources in HDR brachytherapy","volume":"3","author":"Strohmaier","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"R12-32-20241021","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1118\/1.597811","article-title":"Measurement and calculation of the dose at large distances from brachytherapy sources: Cs-137, 192Ir, and 60Co","volume":"23","author":"Venselaar","year":"1996","journal-title":"Med Phys"},{"key":"R13-32-20241021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00066-008-1684-y","article-title":"Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy","volume":"184","author":"Richter","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"R14-32-20241021","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.apradiso.2009.02.066","article-title":"A comparison of dose distributions of HDR intracavitary brachytherapy using different sources and treatment planning systems","volume":"67","author":"Park","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"R15-32-20241021","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.3390\/ijerph9114223","article-title":"Integral dose and radiation-induced secondary malignancies: Comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapy","volume":"9","author":"D'Arienzo","year":"2012","journal-title":"Int J Environ Res Public Health"},{"key":"R16-32-20241021","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1118\/1.2759602","article-title":"Technical note: Dosimetric study of a new co-60 source used in brachytherapy","volume":"34","author":"Granero","year":"2007","journal-title":"Med Phys"},{"key":"R17-32-20241021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no. 43. American Association of Physicists in Medicine","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"R18-32-20241021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM task group no.43 report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"R19-32-20241021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.meddos.2007.11.001","article-title":"Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index","volume":"33","author":"Shi","year":"2008","journal-title":"Med Dosim"},{"key":"R20-32-20241021","first-page":"10","article-title":"The calculation and comparison of integral dose for the rectum, bladder, right and left femur heads in two methods of prostate cancer radiotherapy: S.A.S IMRT vs. 3D CRT","volume":"5","author":"Shirani Tak Abi","year":"2013","journal-title":"BCCR"},{"key":"R21-32-20241021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"R22-32-20241021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society Cervical Cancer Recommendations Committee, American Brachytherapy Society. American brachytherapy society consensus guidelines for locally advanced carcinoma of the cervix. Part I: General principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"R24-32-20241021","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ijrobp.2015.11.024","article-title":"Image guided cervical brachytherapy: 2014 survey of the American Brachytherapy Society","volume":"94","author":"Grover","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-32-20241021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5114\/jcb.2010.14405","article-title":"Dose volume uniformity index: A simple tool for treatment plan evaluation in brachytherapy","volume":"2","author":"Prabhakar","year":"2010","journal-title":"J Contemp Brachytherapy"},{"key":"R26-32-20241021","first-page":"1101","article-title":"High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: Twenty-year experience with cobalt after-loading system","volume":"16","author":"Mosalaei","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R27-32-20241021","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijrobp.2007.10.034","article-title":"Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: Correlation with the integral dose restricted to the irradiated fields","volume":"70","author":"Nguyen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_199_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:25Z","timestamp":1787067445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_199_19"}},"subtitle":["60Co and 192Ir"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_199_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}